Reactive oxygen species (ROS) play essential roles in cellular signaling and homeostasis, and recent evidence has linked excessive ROS generation to skeletal disorders and altered bone remodeling. Among ROS-producing enzymes, NADPH oxidase 4 (NOX4) is...
Reactive oxygen species (ROS) play essential roles in cellular signaling and homeostasis, and recent evidence has linked excessive ROS generation to skeletal disorders and altered bone remodeling. Among ROS-producing enzymes, NADPH oxidase 4 (NOX4) is a major source of hydrogen peroxide (H₂O₂) in bone-forming cells. However, its regulatory relationship with myeloperoxidase (MPO) and osteopontin (OPN) during osteoblast differentiation and endochondral ossification remains unclear. This study aimed to elucidate how NOX4 modulates bone formation through a redox-associated mechanism involving MPO and OPN. To investigate this, NOX4-deficient (NOX4⁻/⁻) and ovariectomized (OVX) mice were analyzed to assess in vivo skeletal morphology and bone maturation. In parallel, primary calvarial osteoblasts derived from wild-type and NOX4⁻/⁻ mice were cultured with or without the irreversible MPO inhibitor 4-aminobenzoic acid hydrazide (4-ABAH). Cellular proliferation, early differentiation, and matrix mineralization were evaluated, along with mRNA and protein expression levels of NOX4, MPO, and OPN. Whole-mount skeletal staining at embryonic day 17.5 (E17.5) provided developmental validation in vivo. The NOX4⁻/⁻ group exhibited enhanced endochondral ossification compared with the control and OVX groups. Proteomic and immunohistochemical analyses showed upregulated MPO and OPN expression near the epiphyseal plate in bones from NOX4⁻/⁻ mice. In vitro, loss of NOX4 promoted osteoblast proliferation, ALP activity, and mineral deposition, whereas MPO inhibition by 4-ABAH suppressed these parameters in a dose-dependent manner. Notably, NOX4⁻/⁻ osteoblast cultures maintained higher osteogenic potential even under MPO inhibition. This study demonstrates that NOX4 deficiency promotes osteoblast differentiation, matrix maturation, and endochondral ossification through the upregulation of MPO and OPN. Our findings identify this regulatory interaction as a distinct redox-modulatory axis that is normally restrained by NOX4. Loss of NOX4 releases this restraint, thereby enhancing osteogenic progression and accelerating mineralized matrix expansion. These results establish the NOX4–MPO–OPN axis as a critical mediator of redox-dependent regulation during bone formation and highlight its potential as a therapeutic target for skeletal disorders associated with oxidative stress and impaired bone metabolism.